Amir Safavi (@safaviaa) 's Twitter Profile
Amir Safavi

@safaviaa

@MSKCancerCenter #RadOnc Fellow ☢️ |🗣️#HNCSM 🫁#LCSM 🧠🦴#OMD | @Columbia @UofTDRO👨‍🎓 | #Adaptive #AI #IO enthusiast | 🎼 & 🏒nerd

ID: 3013396533

calendar_today03-02-2015 00:12:43

5,5K Tweet

920 Followers

597 Following

Teresa Brown (@teresabrownapd) 's Twitter Profile Photo

Great poster by Lachlan McDowell demonstrating patient priorities pre treatment & 12 months post treatment for #HPV #oropharyngeal #scc ➡️ #taste & #smell are increasingly important to patients posttreatment in #survivorship #ANZHNCS24 ANZHNCS

Great poster by <a href="/lachiemcd/">Lachlan McDowell</a> demonstrating patient priorities pre treatment &amp; 12 months post treatment for #HPV  #oropharyngeal #scc ➡️ #taste &amp; #smell are increasingly important to patients posttreatment in #survivorship
#ANZHNCS24 <a href="/anzhncs/">ANZHNCS</a>
UroToday.com (@urotoday) 's Twitter Profile Photo

hK2-targeted radioligand shows promise in treating advanced #ProstateCancer. Michael Morris Memorial Sloan Kettering Cancer Center joins Alicia Morgans, MD, MPH Dana-Farber to discuss phase I findings and the importance of adaptive dosing to balance efficacy and manage side effects > bit.ly/3zZOjUB

hK2-targeted radioligand shows promise in treating advanced #ProstateCancer. <a href="/morr316/">Michael Morris</a> <a href="/MSKCancerCenter/">Memorial Sloan Kettering Cancer Center</a> joins <a href="/CaPsurvivorship/">Alicia Morgans, MD, MPH</a> <a href="/DanaFarber/">Dana-Farber</a> to discuss phase I findings and the importance of adaptive dosing to balance efficacy and manage side effects &gt; bit.ly/3zZOjUB
NRG Oncology (@nrgonc) 's Twitter Profile Photo

ICYMI - we just activated NRG-BN013 (Phase III Trial of Single Fraction Stereotactic Radiosurgery (SRS) Versus Fractionated SRS (FSRS) for Intact Brain Metastases). Read more: conta.cc/3MmoqBt Rupesh Kotecha @theCTSU Miami Cancer Institute Research

ICYMI - we just activated NRG-BN013 (Phase III Trial of Single Fraction Stereotactic Radiosurgery (SRS) Versus Fractionated SRS (FSRS) for Intact Brain Metastases). Read more:  conta.cc/3MmoqBt
<a href="/Rrkotecha/">Rupesh Kotecha</a> @theCTSU <a href="/MiamiCancerInst/">Miami Cancer Institute Research</a>
Dan Marcus (@danimalish) 's Twitter Profile Photo

There’s usually a moment when I’m watching a great film where I know we’re in excellent hands. For THE BATMAN, I knew we were in excellent hands during this introductory sequence. I get chills every time I watch it.

Berliner Philharmoniker (@berlinphil) 's Twitter Profile Photo

🧙 #MotivationMonday: have a magical week with Modest Mussorgsky's programmatic piece Night on Bald Mountain (arr. by Nikolai Rimsky-Korsakov), conducted here by Kirill Petrenko at the 2024 season finale in the Waldbühne. » digitalconcerthall.com/concert/55155?…

Kate Hockemeyer (@hockemeyerkate) 's Twitter Profile Photo

Excited to see our story showing that the #stressresponse regulator #HSF1 modulates NK cell anti-tumour immunity out in ⁦Nature Cell Biology⁩. Thanks to fantastic work with ⁦Nikos Kourtis⁩ ⁦Iannis Aifantis⁩ and team ⁦NYU Langone Health⁩ 🧵👇 nature.com/articles/s4155…

Alison Tree 💙 (@alison_tree) 's Twitter Profile Photo

We might have assumed that MRIgART has little to offer in GBM, but maybe we were wrong! Looking forward to this study being presented at ASTRO Congratulations to Jay Detsky MD arjun sahgal and the whole Sunnybrook Health Sciences Centre team on the award.

Divya Yadav MD (@idivyamd) 's Twitter Profile Photo

Check out our latest article “PSMA PET improves characterization of dural-based intracranial lesions in patients with prostate cancer” published in European Jornal of Radiology sciencedirect.com/science/articl…

Check out our latest article “PSMA PET improves characterization of dural-based intracranial lesions in patients with prostate cancer”
published in European Jornal of Radiology

sciencedirect.com/science/articl…
Fumiko Ladd Chino, MD, FASCO (@fumikochino) 's Twitter Profile Photo

🚨Dr Kaitlyn Lapen categorizes patient costs for #medicalCannabis during #cancer tx. Median 💰 for #cannabis is $80/month. This is EXPENSIVE for a single med without a proven EBM benefit. We need better education & more RCT to show benefits (and harms). 🌿academic.oup.com/jncimono/artic…

🚨Dr <a href="/KaitlynLapen/">Kaitlyn Lapen</a> categorizes patient costs for #medicalCannabis during #cancer tx. Median 💰 for #cannabis is $80/month. 
This is EXPENSIVE for a single med without a proven EBM benefit. We need better education &amp; more RCT to show benefits (and harms).
🌿academic.oup.com/jncimono/artic…
Joe Y Chang (@joechangmd) 's Twitter Profile Photo

Recent Keynote 867 triggered debate about I-SABR strategies in early-stage NSCLC. Molecular biomarkers and AI-guided individualized approaches will improve clinical outcomes. See LANCET, EJC and WCLC on 9/9/24 oral presentation about I-SABR SELECT using AI machine learning.

Recent Keynote 867 triggered debate about I-SABR strategies in early-stage NSCLC. Molecular biomarkers and AI-guided individualized approaches will improve clinical outcomes. See LANCET, EJC and WCLC on 9/9/24 oral presentation about I-SABR SELECT using AI machine learning.
Jelena Lukovic, MD FRCPC MPH (@j_lukovic) 's Twitter Profile Photo

Single fraction RT (8Gy) significantly improves hepatic pain compared with best supportive care and can be considered standard palliative treatment. No increase in toxicity. Laura Dawson CCTG thelancet.com/journals/lanon…

Drew Moghanaki 🐕 (@drewmoghanaki) 's Twitter Profile Photo

Following the published results of LAURA (and ADAURA), it simply isn’t acceptable to manage stage III NSCLC without an EGFR biomarker test result. Especially since Durva doesn’t seem to work for EGFRm tumors after CRT. It’s disheartening to learn this is still happening. #radonc